Rani Therapeutics is a biotherapeutics company that develops orally administered biologics, including the RaniPill capsule which replaces subcutaneous or IV injection of biologics with oral dosing. Rani Therapeutics has a product pipeline that includes various treatments for conditions such as neuroendocrine tumors, acromegaly, psoriatic arthritis, osteoporosis, growth hormone deficiency, and type 2 diabetes. The company was founded in 2012 and is based in San Jose, California.